ABSTRACT
We apply a new serosurveillance tool to estimate typhoidal Salmonella burden from dried blood spots in Juba, South Sudan, finding a seroincidence rate of 35 per 100 person-years and cumulative incidence of 78% over four years.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the World Health Organizations (WHO) Unity Studies, a global seroepidemiologic standardization initiative, with funding provided by the COVID-19 Solidarity Response. This study was also supported by The Bill and Melinda Gates Foundation (INV-000572) and the US National institutes of Health (R01AI134814).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by ethical review boards with the South Sudan Ministry of Health and Mass General Hospital.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: This work was supported by the World Health Organization’s (WHO) Unity Studies, a global seroepidemiologic standardization initiative, with funding provided by the COVID-19 Solidarity Response. This study was also supported by The Bill and Melinda Gates Foundation (INV-000572) and the US National institutes of Health (R01AI134814).
Data Availability
All data produced in the present study are available upon reasonable request to the authors